Cosmos Holdings Engages PGS Ventures to Advise on Strategic Transactions to Accelerate Core Business Expansion CHICAGO, Oct. 16, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has entered into an advisory agreement with PGS Ventures B.V. (PGS), an Amsterdam corporation (the Advisor), to identify and introduce the Company to prospective merger and acquisition candidates, potential sources of capital, and advise on senior exchange listing strategies. Peter Goldstein, the Director ...

CHICAGO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the “Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the first six months ended June 30, 2020, prepared in accordance to Generally Accepted Accounting Principles (US GAAP). Financial Highlights for the three months ended June 30, 2020: -For the three months ended June 30, 2020, revenues increased by 50.6% to $12.8 million from $8.51 million in the same period in 2019. -Quarterly gross profits increased to $2.3 million from ...

CHICAGO, May 20, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (the ‘’Company") (OTCQB: COSM), an international pharmaceutical company, announced consolidated financial results for the fiscal year ended December 31, 2019 and the quarter ended March 31, 2020, prepared in accordance to Generally Accepted Accounting Principles (US GAAP). Financial Highlights for the year ended December 31, 2019: -Operating revenues increased in 2019 by 7.0% to $39.7 Million from $37.1 Million in 2018. -Gross profits improved by 52% year over year. For the twelve months ...

CHICAGO, April 08, 2020 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced today that it has signed a definitive agreement with SunMed Biosciences Limited to be the exclusive representative and distribution agent of a rapid Diagnostic Detection Kit (DDK) into four EU countries: Germany, England, Greece and Cyprus. Specifically, this product is used for qualitative detection of the presence of IgM and/or IgG antibody to SARS-CoV-2, virus that causes COVID-19, in human serum, ...

CHICAGO, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Cosmos Holdings Inc. (OTCQB: COSM) (the “Company”) today announced it has engaged Exchange Listing LLC to assist with the planning and implementation of an up-listing of its common stock to the NASDAQ Capital Markets. “We plan to list our securities on NASDAQ Capital Markets as a next stage in our corporate growth and development,” said Greg Siokas, Chief Executive Officer of Cosmos Holdings. “We believe such a listing will provide a broader trading platform ...